Fimbriae of uropathogenic Proteus mirabilis

FEMS Immunology and Medical Microbiology

Volumn 51, Issue 1, 2007, Pages 1-7

  Rocha, Sérgio P D ^a   Pelayo, Jacinta S ^b   Elias, Waldir P ^a  

^a INSTITUTO BUTANTAN   (Brazil)

^b STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

Biofilm; Fimbria; Proteus mirabilis; Vaccine

Indexed keywords

ADHESIN;

BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BIOFILM; ENVIRONMENTAL TEMPERATURE; FIMBRIA; PRIORITY JOURNAL; PROPHYLAXIS; PROTEUS MIRABILIS; SHORT SURVEY; URINARY TRACT INFECTION;

ADHESINS, BACTERIAL; ANIMALS; BACTERIAL ADHESION; BACTERIAL VACCINES; FIMBRIAE, BACTERIAL; HUMANS; MANNOSE; PROTEUS MIRABILIS; URINARY TRACT INFECTIONS;

EID: 34548594201     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2007.00284.x     Document Type: Short Survey

References (49)

1. Adegbola RA, Old DC Senior BW (1983) The adhesins and fimbriae of Proteus mirabilis strains associated with high and low affinity for the urinary tract. J Med Microbiol 16 : 427 431.
2. Bahrani FK Mobley HLT (1994) Proteus mirabilis MR/P fimbrial operon: genetic organization, nucleotide sequence, and conditions for expression. J Bacteriol 176 : 3412 3419.
3. Bahrani FK, Johnson DE, Robbins D Mobley HLT (1991) Proteus mirabilis flagella and MR/P fimbriae: isolation, purification, n-terminal analysis, and serum antibody response following experimental urinary tract infection. Infect Immun 59 : 3574 3580.
4. Bahrani FK, Cook S, Hull RA, Massad G Mobley HLT (1993) Proteus mirabilis fimbrial N-terminal amino acid sequence of a major fimbrial subunit and nucleotide sequences of the gene from two strains. Infect Immun 61 : 884 891.
5. Bahrani FK, Massad G, Lockatell CV, Johnson DE, Russell RG, Warren JW Mobley HLT (1994) Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection. Infect Immun 176 : 3412 3419.
6. Beachey EH (1981) Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surfaces. J Infect Dis 143 : 325 345.
7. Bijlsma IGW, van Dijk L, Kusters JG Gaastra W (1995) Nucleotide sequence of two major subunits genes, pmpA and ucaA from canine-uropathogenic Proteus mirabilis strains. Microbiology 141 : 1349 1357.
8. Coker C, Poore CA, Li X Mobley HL (2000) Pathogenesis of Proteus mirabilis urinary tract infection. Microbes Infect 12 : 1497 1505.
9. Cook SW, Mody N, Valle J Hull R (1995) Molecular cloning of Proteus mirabilis uroepithelial cell adherence (uca) genes. Infect Immun 63 : 2082 2086.
10. Daifuku R Stamm WE (1986) Bacterial adherence to bladder uroepithelial cells in catheter-associated urinary tract infection. N Engl J Med 314 : 1208 1213.
11. Donlan RM Costerton JW (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15 : 167 193.
12. Edwards RA Puente JL (1998) Fimbrial expression in enteric bacteria: a critical step in intestinal pathogenesis. Trends Microbiol 6 : 282 287.
13. Gerlach GF, Clegg S Allen BL (1989) Identification and characterization of the genes encoding the type 3 and type 1 fimbrial adhesins of Klebsiella pneumoniae. J Bacteriol 171 : 1262 1270.
14. Jansen AM, Lockatell V, Johnson DE Mobley HLT (2004) Mannose-resistant Proteus-like fimbriae are produced by most Proteus mirabilis strains infecting the urinary tract, dictate the in vivo localization of bacteria, and contribute to biofilm formation. Infect Immun 72 : 7294 7305.
15. Johansen TEB, Çek M, Naber KG, Stratchounski L, Svendsen MV Tenke P PEP and PEAP-study investigators and the board of the European Society of Infections in Urology (2006) Hospital acquired urinary tract infections in urology departments: pathogens, susceptibility and use of antibiotics. Data from the PEP and PEAP-studies. Int J Antimicrob Agents 28 (suppl 1), 91 107.
16. Kahlmeter G (2000) The ECO. SENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens-interim report. Int J Antimicrob Agents 46 (suppl 1), 15 22.
17. Latta RK, Schur MJ, Tolson DL Altman E (1998) The effect of growth conditions on in vitro adherence, invasion, and NAF expression by Proteus mirabilis 7570. Can J Microbiol 44 : 896 904.
18. Lee KK, Harrison BA, Latta R Altman E (2000) The binding of Proteus mirabilis nonagglutinating fimbriae to ganglio-series asialoglycolipids and lactosyl ceramide. Can J Microbiol 46 : 961 966.
19. Li X Mobley HLT (2002) Vaccines for Proteus mirabilis in urinary tract. Int J Antimicrobial Agents 19 : 461 465.
20. Li X, Johnson DE Mobley HLT (1999) Requirement of MrpH for manose-resistant Proteus-like fimbriae-mediated hemaglutination by Proteus mirabilis. Infect Immun 67 : 2822 2833.
21. Li X, Rasko DA, Lockatell CV, Johnson DE Mobley HLT (2001) Repression of bacterial motility by a novel fimbrial gene product. EMBO J 20 : 4854 4862.
22. Li X, Lockatell CV, Johnson DE, Lane MC, Warren JW Mobley HLT (2004) Development of an intranasal vaccine to prevent urinary tract infection by Proteus mirabilis. Infect Immun 72 : 66 75.
23. Lingwood CA (1992) Bacterial adhesions/glycolipid receptors. Curr Opin Struct Biol 2 : 693 700.
24. Massad G Mobley HLT (1994) Genetic organization and complete sequence of the Proteus mirabilis pmf fimbrial operon. Gene 150 : 101 104.
25. Massad G, Bahrani FK Mobley HLT (1994a) Proteus mirabilis fimbriae: identification, isolation, and characterization of a new ambient-temperature fimbriae. Infect Immun 62 : 1989 1994.
26. Massad G, Lockattell CV, Johson DE Mobley HLT (1994b) Proteus mirabilis fimbriae: construction of an isogenic pmfA mutant and analysis of virulence in a CBA mouse model of ascending urinary infection. Infect Immun 62 : 536 542.
27. Massad G, Fulkerson JJ, Watson DC Mobley HLT (1996) Proteus mirabilis ambient-temperature fimbriae: cloning and nucleotide sequence of the atf gene cluster. Infect Immun 64 : 4390 4395.
28. Moayeri N, Collins CM O'Hanley P (1991) Efficacy of a Proteus mirabilis outer membrane protein vaccine in preventing experimental Proteus pyelonephritis in a BALB/c mouse model. Infect Immun 59 : 3778 3786.
29. Mobley HLT (2000) Virulence of the two primary uropathogens. ASM News 66 : 403 410.
30. Mobley HLT Belas R (1995) Swarming and pathogenicity of Proteus mirabilis in the urinary tract. Trends Microbiol 3 : 280 284.
31. Morris NS, Stickler DJ Winters C (1997) Which indwelling urethral catheters resist encrustation by Proteus mirabilis biofilms? Br J Urol 80 : 58 63.
32. Nataro JP, Kaper JB, Robins-Browne R, Prado V, Vial P Levine MM (1987) Patterns of adherence of diarrheagenic Escherichia coli to HEp-2 cells. Pediatr Infect Dis J 6 : 829 831.
33. Old DC Adegbola RA (1983) A new mannose-resistant haemagglutinin in Klebsiella. J Appl Bacteriol 55 : 165 172.
34. Pellegrino R, Galvalisi U, Scavone P, Sosa V Zunino P (2003) Evaluation of Proteus mirabilis structural fimbrial proteins as antigens against urinary tract infections. FEMS Immunol Med Microbiol 36 : 103 110.
35. Rozalski A, Sidorczyk Z Kotelko K (1997) Potential virulence factors of Proteus bacilli. Microbiol Mol Biol Rev 61 : 65 89.
36. Sabbuba N, Hughes G Stickler DJ (2002) The migration of Proteus mirabilis and other urinary tract pathogens over Foley catheters. BJU Int 89 : 55 60.
37. Sareneva T, Holthöfer H Korhonen TK (1990) Tissue-binding affinity of Proteus mirabilis fimbriae in the human urinary tract. Infect Immun 58 : 3330 3336.
38. Scavone P, Sosa V, Pellegrino R, Galvalisi U Zunino P (2004) Mucosal vaccination of mice with recombinant Proteus mirabilis structural fimbrial proteins. Microbes Infect 6 : 853 860.
39. Soto GE Hultgren SJ (1999) Bacterial adhesions: common themes and variations in architecture and assembly. J Bacteriol 181 : 1059 1071.
40. Svamborg EC, Larsson P Lomberg H (1980) Attachment of Proteus mirabilis to human urinary sediment epithelial cells in vitro is different from that of Escherichia coli. Infect Immun 27 : 804 807.
41. Tolson DL, Barrigar DL, Mclean RJC Altman E (1995) Expression of a nonagglutinating fimbria by Proteus mirabilis. Infect Immun 63 : 1127 1129.
42. Tolson DL, Harrison BA, Latta RK, Lee KK Altman E (1997) The expression of nonagglutinating fimbriae and its role in Proteus mirabilis adherence to epithelial cells. Can J Microbiol 43 : 709 717.
43. Warren JW, Tenney JH, Hoopes JM Kass EH (1982) A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis 146 : 719 723.
44. Wray SK, Hull SI, Cook RG, Barrish J Hull RA (1986) Identification and characterization of an uroepithelial cell adhesion from an uropathogenic isolate of Proteus mirabilis. Infect Immun 54 : 43 49.
45. Yakubu DE, Old DC Senior BW (1989) The haemagglutinins and fimbriae of Proteus penneri. J Med Microbiol 30 : 279 284.
46. Zhao H, Li X, Johnson DE, Bolnfield I Mobley HLT (1997) In vivo phase variation of MR/P fimbrial gene expression in Proteus mirabilis infecting the urinary tract. Mol Microbiol 48 : 1009 1019.
47. Zunino P, Geymonat L, Allen AG, Legnani-Fajardo C Maskell DJ (2000) Virulence of a Proteus mirabilis ATF isogenic mutant is not impaired in a mouse model of ascending urinary tract infection. FEMS Immunol Med Microbiol 29 : 137 144.
48. Zunino P, Geymonat L, Allen AG, Preston A, Sosa V Maskell DJ (2001) New aspects of the role of MR/P fimbriae in Proteus mirabilis urinary tract infection. FEMS Immunol Med Microbiol 31 : 113 120.
49. Zunino P, Sosa V, Allen AG, Preston A, Geraldine S Maskell DJ (2003) Proteus mirabilis fimbriae (PMF) are important for both bladder and kidney colonization in mice. Microbiol 149 : 3231 3237.